Introductions Curative surgical resection cannot be an option for most patients with hepatocellular carcinoma (HCC) because of underlying liver disease or extent of tumor. Radiotherpay (RT) for HCC is not generally considered a treatment of choice but RT has been used in advanced HCC patients such as portal venous tumor thrombosis (PVTT) and multiple large tumors. Recently, some studies showed that RT may be bridge to living donor liver transplant (LDLT). We report our experience with RT as pretransplant therapy. Methods Between May 1996 and March 2013, total 1360 patients treated by LT in our institution. Thirteen patients had history of RT and we analyze these patients retrospectively. Objective tumor response is evaluated with CT and/or MRI according to modified RECIST criteria and outcomes is estimated by disease free survival (DFS) and overall survival (OS). Results Before RT, seven patients exceed Milan criteria, and four patients have PVTT. Three patients are multiple HCC and all patients are LDLT and interval between RT and LDLT is 719.7 days. There was no significant difference between RT with LDLT and LDLT alone in operation times and amount of intraoperative transfusion. 3, 6 months and 1 year DFS is 82.5%, 73.3%, 55.0%, respectively. As shown in [table 1] and [table 2], low AFP group (<20ng/mL) and good objective tumor response after RT group have good prognosis compare with the other group. Conclusions LDLT is feasible in advanced HCC patients who have low AFP levels and good tumor response after RT.Table: No Caption available.Table: No Caption available.